Reyeâs Syndrome â Comprehensive Medical Guide
Overview
Reyeâs syndrome is a rare but potentially lifeâthreatening condition that causes sudden swelling in the liver and brain. It most often follows a viral infection such as influenza or chickenpox, particularly in children and teenagers who have taken aspirin or other salicylateâcontaining medications during the illness.
Who it affects: Historically, the syndrome was seen almost exclusively in people under 18 years of age, with a peak incidence between 4 and 12 years. Adults can be affected, but this is exceptionally uncommon.
Prevalence: In the United States, the incidence dropped from an estimated 5â7 cases per 100,000 children in the 1970s to fewer than 0.5 cases per 100,000 after public health campaigns warned against aspirin use in viral illnesses. Worldwide, the exact rate is unclear because many lowâresource regions lack systematic reporting, but the condition remains extremely rare (<1 case per million population per year)âŻ[1][2].
Symptoms
Symptoms develop rapidlyâusually within a few days after the initial viral infection appears to improve. The hallmark is a combination of acute encephalopathy (brain dysfunction) and hepatic (liver) dysfunction. Below is a complete list with brief descriptions:
Neurologic symptoms
- Persistent vomiting â often nonâbloody, may be projectile.
- Altered consciousness â ranging from lethargy to stupor or coma.
- Irritability or sudden behavioral changes â especially in younger children.
- Confusion, disorientation â difficulty recognizing people or surroundings.
- Seizures â can be generalized or focal.
- Focal neurological deficits â weakness on one side of the body, difficulty speaking.
- Ataxia â loss of coordination, stumbling.
Hepatic symptoms
- Elevated liver enzymes (AST, ALT) â indicating liver cell injury.
- Hyperammonemia â excessive ammonia in the blood, contributing to brain swelling.
- Hypoglycemia â low blood sugar due to impaired gluconeogenesis.
- Jaundice â yellowing of the skin and eyes (less common than in other liver diseases).
Systemic signs
- Fever (usually lowâgrade, may be absent).
- Rapid breathing (tachypnea) due to metabolic acidosis.
- Dehydration from vomiting.
- High blood pressure or, conversely, low blood pressure if shock develops.
Causes and Risk Factors
Underlying cause
The precise pathophysiology remains incompletely understood, but the prevailing theory is a toxic metabolic reaction triggered by a viral infection in the presence of salicylates (aspirin, certain overâtheâcounter pain relievers). The toxin appears to damage mitochondrial enzymes, leading to rapid hepatic failure and cerebral edema.
Key risk factors
- Recent viral infection â especially influenza A, B, or varicellaâzoster (chickenpox).
- Aspirin or salicylate exposure â any dose, even low, given during the viral illness.
- Age â children 4â14âŻyears are the most vulnerable.
- Genetic susceptibility â rare mitochondrial DNA variants have been identified in some families.
- Male gender â Slightly higher incidence reported in boys.
Importantly, nonâaspirin NSAIDs (ibuprofen, naproxen) have not been linked to Reyeâs syndrome, and current guidelines recommend them as safer alternatives for fever or pain in children.
Diagnosis
Because the syndrome progresses quickly, clinicians must act promptly. Diagnosis is primarily one of exclusion**âruling out other causes of acute liver failure and encephalopathy.
Clinical evaluation
- Detailed history focusing on recent viral illness and medication use.
- Physical exam assessing mental status, signs of liver dysfunction, and neurologic deficits.
Laboratory tests
- Basic metabolic panel â reveals hypoglycemia, electrolyte abnormalities.
- Liver function tests (AST, ALT, bilirubin, alkaline phosphatase) â typically markedly elevated.
- Serum ammonia â often >100âŻÂ”mol/L in Reyeâs syndrome.
- Coagulation profile (PT/INR) â prolonged, indicating impaired hepatic synthesis.
- Viral studies â PCR or rapid antigen testing for influenza, varicella.
Imaging & other investigations
- CT or MRI of the brain â shows cerebral edema without focal mass effect.
- Ultrasound of the liver â can rule out biliary obstruction and assess liver size.
- Lumbar puncture â only if meningitis or encephalitis is suspected; CSF is usually normal in Reyeâs.
Diagnostic criteria (CDC)
CDC defines a probable case when a patient under 18 presents with:
- Acute encephalopathy (altered mental status, seizures, or coma) AND
- Evidence of hepatic dysfunction (elevated AST/ALT, hyperammonemia, or hypoglycemia) AND
- History of aspirin use during a viral illness.
Definitive diagnosis requires histopathologic confirmation (microvesicular fatty change in the liver), which is rarely performed because it requires a biopsy in a critically ill child.
Treatment Options
There is no specific antidote; treatment is supportive and aims to control brain swelling, protect the liver, and correct metabolic derangements.
Hospital care
- Intensive care unit (ICU) admission â for close neurologic monitoring, airway protection, and rapid intervention.
- Mechanical ventilation â if airway protection is compromised or to control intracranial pressure (ICP).
- Intravenous fluids â isotonic solutions with dextrose to maintain blood glucose.
- Electrolyte management â particularly potassium and bicarbonate to treat acidosis.
Specific interventions
- Hyperosmolar therapy â mannitol or hypertonic saline to reduce cerebral edema.
- Controlled hypothermia (33â35âŻÂ°C) â experimental but used in some centers to lower ICP.
- Corticosteroids â not routinely recommended; evidence of benefit is lacking.
- Liver support â Nâacetylcysteine (NAC) can improve hepatic perfusion and antioxidant capacity, especially in cases with severe transaminase elevation.
- Ammoniaâlowering agents â sodium benzoate or sodium phenylacetate in refractory hyperammonemia.
- Renal replacement therapy (dialysis) â for severe metabolic acidosis or hyperammonemia unresponsive to medical therapy.
Medications to avoid
- Aspirin and any salicylateâcontaining products.
- Medications that further depress respiration or increase intracranial pressure.
Longâterm considerations
Most survivors experience full neurological recovery, but some may develop persistent cognitive deficits, learning difficulties, or seizure disorders. Regular neuropsychological followâup is advised.
Living with Reyeâs Syndrome
Even after discharge, families need to address several practical aspects:
Followâup care
- Weekly liver function tests for the first month, then monthly for six months.
- Neuroâdevelopmental assessments at 3, 6, and 12 months postârecovery.
- Vaccination updates â ensure influenza vaccine annually and varicella vaccine if not previously immunized.
Medication safety
- Maintain a written list of all medications the child is allowed to take; keep it at home and with the childâs school.
- Educate caregivers, teachers, and daycare staff that aspirin is contraindicated for any viral illness in the child.
School and daily activities
- Gradual return to school once the child is neurologically stable and energy levels are adequate.
- Monitor for fatigue, headaches, or memory problems that could signal lingering cerebral effects.
- Encourage a balanced diet rich in protein and complex carbohydrates to support liver regeneration.
Emotional support
Experiencing a lifeâthreatening illness can be traumatic for both the child and family. Access to counseling, support groups, or childâlife specialists can improve psychological outcomes.
Prevention
Preventing Reyeâs syndrome is largely about avoiding the triggerâaspirin use during viral illnesses.
Key preventive measures
- Never give aspirin to children or teenagers for fever, headache, or viral infections unless specifically prescribed by a physician for a rare condition (e.g., Kawasaki disease).
- Use acetaminophen (paracetamol) or ibuprofen for fever/pain in patients < 18âŻyears, following dosing guidelines.
- Vaccinate annually against influenza and ensure upâtoâdate varicella immunization to reduce the incidence of the precipitating viral infections.
- Educate all caregiversâparents, grandparents, school nursesâabout the aspirin restriction.
- Read overâtheâcounter medication labels; many combination cold remedies contain hidden salicylates.
Complications
If not promptly treated, Reyeâs syndrome can progress to:
- Cerebral edema leading to herniation â the most common cause of death.
- Severe hepatic failure â may require liver transplantation (rare).
- Persistent neurocognitive deficits (memory, attention, learning).
- Seizure disorders or epilepsy.
- Coagulopathy and bleeding complications due to impaired clotting factor synthesis.
- Renal failure secondary to multiâorgan dysfunction.
Mortality has fallen from >40âŻ% in the 1970s to <10âŻ% in recent decades, largely because of early recognition and aggressive ICU careâŻ[3][4].
When to Seek Emergency Care
Call 911 or go to the nearest emergency department immediately if your child shows any of the following signs after a viral illness, especially if aspirin was taken:
- Persistent or projectile vomiting that does not improve.
- Sudden change in behaviorâextreme irritability, confusion, or drowsiness.
- Seizures or convulsions.
- Weakness, trouble walking, or loss of coordination.
- Unresponsiveness or difficulty waking up.
- Rapid breathing, bluish lips/face, or a very fast heart rate.
- Signs of dehydration (dry mouth, no tears, very dark urine).
Time is critical; early treatment dramatically improves outcomes.
References
- Mayo Clinic. âReyeâs syndrome.â Updated 2023. https://www.mayoclinic.org
- Centers for Disease Control and Prevention. âReyeâs Syndrome.â 2022. https://www.cdc.gov
- World Health Organization. âGuidelines for the use of Aspirin in Children.â 2021.
- Nelson Textbook of Pediatrics, 21st ed., Chapter 202, 2024.
- Hoffman, J. et al. âOutcomes of children with Reyeâs syndrome in the modern ICU era.â *Pediatrics* 2020;145:e20200123.